Skip to main content
. Author manuscript; available in PMC: 2016 Aug 28.
Published in final edited form as: CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):463–468. doi: 10.2174/187152712800792884

Table 2.

Bioinformative Details of the Studied Interactions

Ligand/Properties [4-(Propan-2-yl) Phenyl]Carbamic Acid L-Tyrosine L-DOPA Norepinephrine Epinephrine
Number of conformations in best cluster 3 13 14 92 22
RMSD from reference structure (angstrom) 63.31 63.48 63.59 64.51 54.45
Estimated Free Energy of Binding (kcal/mol) −6.95 −5.96 −5.6 −8.52 −4.56
Estimated Inhibition Constant, Ki (μM) 8 42.74 79.17 0.569 457.64
Final Intermolecular Energy (kcal/mol) −7.85 −7.75 −7.68 −10.31 −6.35
vdW + Hbond + desolv Energy (kcal/mol) −3.28 −2.17 −2.55 −5.98 −4.79
Electrostatic Energy (kcal/mol) −4.79 −5.58 −5.13 −4.33 −1.56
Final Total Internal Energy (kcal/mol) −0.05 −1.28 −1.83 0.1 −0.59
Torsional Free Energy (kcal/mol) 0.89 1.79 2.09 1.79 1.79
Unbound System’s Energy (kcal/mol) −0.05 −1.28 −1.83 0.1 −0.59
Temperature (K) 298.15 298.15 298.15 298.15 298.15